210 related articles for article (PubMed ID: 36717813)
1. Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line.
Chen A; Ye S; Zheng J; Li J; Chen Z; Zhang Y; Li S
BMC Vet Res; 2023 Jan; 19(1):22. PubMed ID: 36717813
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a new triple-negative canine mammary cancer cell line.
Zhang H; Pei S; Zhou B; Wang H; Du H; Zhang D; Lin D
Tissue Cell; 2018 Oct; 54():10-19. PubMed ID: 30309498
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a multi-drug resistant cell line for canine mammary tumors.
Zhou C; Lin Z; Li X; Zhang D; Song P
Front Vet Sci; 2023; 10():1129756. PubMed ID: 37077947
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor-α, progesterone receptor, and c-
Kabir FML; DeInnocentes P; Agarwal P; Mill CP; Riese Nd DJ; Bird RC
J Vet Sci; 2017 Jun; 18(2):149-158. PubMed ID: 27515268
[TBL] [Abstract][Full Text] [Related]
5. Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT.
Raposo LR; Roma-Rodrigues C; Faísca P; Alves M; Henriques J; Carvalheiro MC; Corvo ML; Baptista PV; Pombeiro AJ; Fernandes AR
Vet Comp Oncol; 2017 Sep; 15(3):952-967. PubMed ID: 27140424
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a New Cell Line of Canine Mammary Tumor CMT-1026.
Mei C; Xin L; Liu Y; Lin J; Xian H; Zhang X; Hu W; Xia Z; Wang H; Lyu Y
Front Vet Sci; 2021; 8():744032. PubMed ID: 34712723
[TBL] [Abstract][Full Text] [Related]
7. A Novel Canine Mammary Cancer Cell Line: Preliminary Identification and Utilization for Drug Screening Studies.
Li R; Wu H; Sun Y; Zhu J; Tang J; Kuang Y; Li G
Front Vet Sci; 2021; 8():665906. PubMed ID: 34124226
[TBL] [Abstract][Full Text] [Related]
8. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of the Epithelial-Mesenchymal Transition in Primary and Paired Metastatic Canine Mammary Carcinomas.
Raposo-Ferreira TMM; Brisson BK; Durham AC; Laufer-Amorim R; Kristiansen V; Puré E; Volk SW; Sorenmo K
Vet Pathol; 2018 Sep; 55(5):622-633. PubMed ID: 29788797
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a new cell line of canine inflammatory mammary cancer: IMC-118.
Gao H; Zhou H; Gao Y; He L; Li W; Xu M; Feng H; Feng X; Qiu C
Vet Comp Oncol; 2022 Sep; 20(3):679-687. PubMed ID: 35429113
[TBL] [Abstract][Full Text] [Related]
11. Characterization of neoplastic cells outlining the cystic space of invasive micropapillary carcinoma of the canine mammary gland.
Rodrigues MA; Caldeira-Brant AL; Gomes DA; Silveira TL; Chiarini-Garcia H; Cassali GD
BMC Vet Res; 2021 Mar; 17(1):130. PubMed ID: 33761962
[TBL] [Abstract][Full Text] [Related]
12. Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry.
Peña L; Gama A; Goldschmidt MH; Abadie J; Benazzi C; Castagnaro M; Díez L; Gärtner F; Hellmén E; Kiupel M; Millán Y; Miller MA; Nguyen F; Poli A; Sarli G; Zappulli V; de las Mulas JM
Vet Pathol; 2014 Jan; 51(1):127-45. PubMed ID: 24227007
[TBL] [Abstract][Full Text] [Related]
13. Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin.
Hellmén E; Moller M; Blankenstein MA; Andersson L; Westermark B
Breast Cancer Res Treat; 2000 Jun; 61(3):197-210. PubMed ID: 10965996
[TBL] [Abstract][Full Text] [Related]
14. Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines.
Hsiao YL; Hsieh TZ; Liou CJ; Cheng YH; Lin CT; Chang CY; Lai YS
BMC Vet Res; 2014 Sep; 10():229. PubMed ID: 25267010
[TBL] [Abstract][Full Text] [Related]
15. p63: a novel myoepithelial cell marker in canine mammary tissues.
Gama A; Alves A; Gartner F; Schmitt F
Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
[TBL] [Abstract][Full Text] [Related]
16. AE1/AE3, vimentin and p63 immunolocalization in canine mammary gland tumours: roles in differentiation between luminal epithelial and myoepithelial lineages.
Toniti P; Sirivisoot S; Jandee P; Srimontri P; Puchadapirom P; Doungchawee G; Kasorndorkbua C
Asian Pac J Cancer Prev; 2010; 11(1):227-30. PubMed ID: 20593961
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 expression, serum tumor markers, and immunohistochemistry in canine mammary tumors.
Ramadan ES; Salem NY; Emam IA; AbdElKader NA; Farghali HA; Khattab MS
Vet Res Commun; 2022 Jun; 46(2):377-388. PubMed ID: 34787777
[TBL] [Abstract][Full Text] [Related]
18. Myoepithelial cells in canine mammary tumours.
Sánchez-Céspedes R; Millán Y; Guil-Luna S; Reymundo C; Espinosa de Los Monteros A; Martín de Las Mulas J
Vet J; 2016 Jan; 207():45-52. PubMed ID: 26639832
[TBL] [Abstract][Full Text] [Related]
19. The dog as a natural animal model for study of the mammary myoepithelial basal cell lineage and its role in mammary carcinogenesis.
Rasotto R; Goldschmidt MH; Castagnaro M; Carnier P; Caliari D; Zappulli V
J Comp Pathol; 2014; 151(2-3):166-80. PubMed ID: 24975897
[TBL] [Abstract][Full Text] [Related]
20. AGR2-mediated unconventional secretion of 14-3-3ε and α-actinin-4, responsive to ER stress and autophagy, drives chemotaxis in canine mammary tumor cells.
Yuan SH; Wu CC; Wang YC; Chan XY; Chu HW; Yang Y; Liu HP
Cell Mol Biol Lett; 2024 May; 29(1):84. PubMed ID: 38822246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]